Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05723315

Effect of rhBNP on CMD in Patients With STEMI After PPCI

Conditions: STEMI

Sex: All
Ages: 18 Years – 80 Years
Phase: NA
Enrollment: 160
Sponsor: Henan Institute of Cardiovascular Epidemiology

Summary

The target population of this interventional study was STEMI patients. Primary discussion: Early rhBNP reduces microcirculation obstruction in STEMI patients undergoing primary PCI

Eligibility Criteria

Inclusion Criteria:STEMIPPCI within 24 hours of symptom onsetTarget vessel QFR-MR>250mm Hg*s/mExclusion Criteria:claustrophobiaPostoperative TIMI grade 0-1Pregnancy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05723315). StuddyBuddy aggregates publicly available trial information.